hypidone
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 24, 2018 (NCT03404466)
Timeline
Indications
Studied for
Mechanism of action
- Monoamine oxidaseINHIBITOR
Monoamine oxidase inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04598607 | Phase 1 | Oct 30, 2020 | Zhejiang Huahai Pharmaceutical Co., Ltd. |
| NCT03739632 | Phase 2 | Nov 15, 2018 | Synergy Pharmaceuticals |
| NCT03404466 | Phase 1/Phase 2 (Phase 2) | Jan 24, 2018 | Synergy Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Synergy Pharmaceuticals | For profit | 2 | 2 | 1 | 2018 |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | For profit | 1 | 1 | 1 | 2020 |
2 organizations
Page 1 / 1